Co-Authors
This is a "connection" page, showing publications co-authored by Maurizio Sanguinetti and Giulia Menchinelli.
Connection Strength
0.876
-
SARS-CoV-2 Antigen Detection to Expand Testing Capacity for COVID-19: Results from a Hospital Emergency Department Testing Site. Diagnostics (Basel). 2021 Jul 05; 11(7).
Score: 0.239
-
Lumipulse G SARS-CoV-2 Ag assay evaluation using clinical samples from different testing groups. Clin Chem Lab Med. 2021 07 27; 59(8):1468-1476.
Score: 0.235
-
Assessment of SARS-CoV-2 RNA Test Results Among Patients Who Recovered From COVID-19 With Prior Negative Results. JAMA Intern Med. 2021 05 01; 181(5):702-704.
Score: 0.059
-
Risk Factors for Mortality in Adult COVID-19 Patients Who Develop Bloodstream Infections Mostly Caused by Antimicrobial-Resistant Organisms: Analysis at a Large Teaching Hospital in Italy. J Clin Med. 2021 Apr 17; 10(8).
Score: 0.059
-
Saliva Is a Valid Alternative to Nasopharyngeal Swab in Chemiluminescence-Based Assay for Detection of SARS-CoV-2 Antigen. J Clin Med. 2021 Apr 02; 10(7).
Score: 0.059
-
Re-evaluating positive serum samples for SARS-CoV-2-specific IgA and IgG antibodies using an in-house serological assay. Clin Microbiol Infect. 2021 Jan 02.
Score: 0.058
-
Performance of a novel diagnostic assay for rapid SARS-CoV-2 antigen detection in nasopharynx samples. Clin Microbiol Infect. 2021 Mar; 27(3):487-488.
Score: 0.057
-
Evaluation of three commercial assays for SARS-CoV-2 molecular detection in upper respiratory tract samples. Eur J Clin Microbiol Infect Dis. 2021 Feb; 40(2):269-277.
Score: 0.056
-
Evaluating the newly developed BioFire COVID-19 test for SARS-CoV-2 molecular detection. Clin Microbiol Infect. 2020 Dec; 26(12):1699-1700.
Score: 0.056